Effect and mechanism of recombinant human fibroblast growth factor 18 on osteoporosis in OVX mice

P. Y. Lu,M. Huang,M. H. Shao,J. X. Hu,C. Y. Ding,Y. J. Feng,M. Zhang,H. P. Lin,H. S. Tian
DOI: https://doi.org/10.1080/13697137.2024.2302967
2024-01-28
Climacteric
Abstract:Objectives This study aimed to investigate the effect and the mechanism of recombinant human fibroblast growth factor 18 (rhFGF18) on postmenopausal osteoporosis.
obstetrics & gynecology
What problem does this paper attempt to address?